With 90% in-house analysis, Novasep’s QC experts have developed an internal platform method for fast ADC characterization. The method, presented in this case study, is now used for customer projects.
Novasep was approached by a top 10 pharmaceutical company looking for a reliable partner to manufacture an ADC payload. The product was in clinical trial Phase I to treat cancer, and the customer first required a validation at 100g scale with prior optimization of the initial medchem process.
Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP antibody drug conjugate. The ADC was in clinical trial Phase I to treat solid tumors, and the customer required a quantity of ADC within 4 months starting from 100g monoclonal antibody.